Xenon Pharmaceuticals Inc... (XENE)
40.19
0.54 (1.36%)
At close: Jan 15, 2025, 1:01 PM
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
| Net Income | -182.39M | -125.37M | -78.88M | -28.84M | -41.59M | -34.50M | -30.70M | -23.00M | -15.75M | 13.02M | 12.03M | -4.30M | -11.99M |
| Depreciation & Amortization | 3.54M | 1.62M | 906.00K | 644.00K | 429.00K | 586.00K | 649.00K | 864.00K | 1.04M | 738.00K | 705.00K | 786.00K | 1.13M |
| Stock-Based Compensation | 32.37M | 20.38M | 10.02M | 5.68M | 2.92M | 2.63M | 2.24M | 2.16M | 3.73M | 760.00K | 648.00K | 414.00K | 447.00K |
| Other Working Capital | 1.57M | -10.49M | -2.19M | -25.06M | 34.17M | -145.00K | 178.00K | 529.00K | -13.85M | -14.41M | -16.60M | 36.19M | 7.74M |
| Other Non-Cash Items | -4.19M | 5.66M | 1.05M | 766.00K | 223.00K | -4.11M | 11.00K | -63.00K | -63.00K | -66.00K | -115.00K | 260.00K | 78.00K |
| Deferred Income Tax | -292.00K | -44.00K | 58.00K | -285.00K | -133.00K | 646.00K | -1.47M | -1.30M | 6.90M | 72.00K | 83.00K | 996.00K | -88.00K |
| Change in Working Capital | 5.63M | -676.00K | -2.65M | -26.09M | 33.52M | 30.00K | 556.00K | 1.77M | -13.96M | -14.26M | -16.68M | 47.42M | -3.27M |
| Operating Cash Flow | -145.33M | -98.43M | -69.50M | -48.12M | -4.63M | -34.72M | -28.73M | -19.57M | -18.10M | 266.00K | -3.32M | 45.57M | -13.69M |
| Capital Expenditures | -5.62M | -2.89M | -2.05M | -2.64M | -1.24M | -507.00K | -315.00K | -279.00K | -551.00K | -1.53M | -156.00K | -526.00K | -290.00K |
| Acquisitions | n/a | 296.00M | -144.75M | -214.71M | -75.44M | -48.52M | -52.62M | n/a | n/a | -13.54M | n/a | n/a | n/a |
| Purchase of Investments | -793.91M | -551.14M | -389.47M | -228.90M | -140.49M | -77.00M | -28.01M | -47.56M | n/a | -15.25M | -17.88M | n/a | n/a |
| Sales Maturities Of Investments | 682.35M | 258.03M | 144.75M | 214.71M | 75.44M | 48.52M | 52.62M | n/a | 10.74M | 13.54M | 6.55M | 1.01M | 14.18M |
| Other Investing Acitivies | n/a | -296.00M | 144.75M | 214.71M | 75.44M | 48.52M | 52.62M | -47.56M | 10.74M | 13.54M | 10.00K | 7.00K | n/a |
| Investing Cash Flow | -117.17M | -296.00M | -246.77M | -16.82M | -66.29M | -28.99M | 24.29M | -47.84M | 10.19M | -3.24M | -11.47M | 491.00K | 13.89M |
| Debt Repayment | n/a | n/a | n/a | -16.74M | n/a | 8.45M | 6.89M | n/a | n/a | n/a | -1.70M | n/a | n/a |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 35.00K | 705.00K | 260.00K | 82.00K | 122.00K | 288.00K | 177.00K | 132.00K | n/a | -1.52M | -2.74M | n/a | n/a |
| Financial Cash Flow | 353.52M | 278.47M | 447.54M | 85.80M | 27.52M | 111.59M | 7.07M | 23.96M | 278.00K | 41.12M | -4.39M | n/a | 2.00K |
| Net Cash Flow | 91.40M | -118.45M | 130.68M | 20.25M | -43.00M | 47.27M | 3.39M | -41.56M | -13.38M | 34.08M | -22.21M | 46.23M | -112.00K |
| Free Cash Flow | -150.94M | -101.32M | -71.55M | -50.76M | -5.87M | -35.23M | -29.04M | -19.85M | -18.65M | -1.26M | -3.48M | 45.05M | -13.98M |